ClinicalTrials.gg
CompletedNCT03835403Updated May 15, 2026

The HeartRunner Trial

An interventional study of Activation of HeartRunners in Out-Of-Hospital Cardiac Arrest, sponsored by Emergency Medical Services, Capital Region, Denmark. Completed at 1 site in Denmark. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Emergency Medical Services, Capital Region, Denmark · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,114
Allocation
Randomized
Ages
8 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark — 1 open to participants now, 1 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · Emergency Medical Services, Capital Region, Denmark.

Started
2019
with 3 others
No phase
4 of 12
1 open now
Registered
2nd of 12
by date

Among the 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark, this one is one of 4 that started in 2019, is one of 4 with no phase, and was the 2nd registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

1 of the 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 8 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark, or all of them as a file.
02

Study summary

The study will assess 30-day survival for cases where volunteer citizen responders ('heart runners') were activated through a smartphone app to retrieve an AED in case of suspected out-of-hospital cardiac arrest (OHCA) versus standard emergency medical services care. The study will randomize emergency medical dispatch center incoming calls which are suspected out-of-hospital cardiac arrest, such that half will be randomized to activation of heart runners and half to no activation of heart runners (standard care). The study will also assess physical or psychological risks involved for the activated heart runners.

Read the detailed description

Chances of survival after out-of-hospital cardiac arrest decrease 10% per minute from collapse until defibrillation. Activating volunteer citizens through the emergency medical dispatch center can potentially increase rates of bystander defibrillation and survival. The HeartRunner trial will investigage the effect of activating registered volunteer citizens through a mobile app integrated with the emergency medical services on 30-day survival following out-of-hospital cardiac arrest. Both arms will receive standard care by the Emergency Medical Services. The intervention arm will additionally receive the activation of volunteer citizen responders. The randomization will take place independently in 3 different strata according to heart runner distance to OHCA (\< 3 min, 3-9 min, > 9 min). The trial will also assess whether it is safe, both physically and psychologically, to activate volunteer citizen responders to respond to out-of-hospital cardiac arrests.

03

Conditions studied

  • Out-Of-Hospital Cardiac Arrest
04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All out-of-hospital cardiac arrests recognized by Emergency Medical Dispatcher and where the HeartRunner system is activated.
  • Non-traumatic etiology, this excludes intoxication, drowning or suicide.
  • Age > 7 years

Exclusion criteria

Exclusion Criteria:

  • Caller is not in direct contact with the patient
  • If Emergency Medical Dispatcher deems AED is not indicated, e.g., in nursing homes where trained personal is present.
  • OHCAs not treated by the EMS due to ethical reasons or obvious signs of death
  • OHCAs with no heart runners within 1800 meters
  • Not true cardiac arrest (suspected, but not verified)
  • EMS-witnessed OHCAs

Emergency medical dispatchers are instructed not to activate heart runners in case any of the exclusion criteria above. However, since it can be challenging for emergency medical dispatchers to gather sufficient information about the patient within the first few minutes, heart runners will admittedly be activated even though they should not have been. Since randomization will occur for all cases in which a heart runner is activated, cases with any of the exclusion criteria will be secondarily excluded.

These cases will be accounted for but not included in analyses of outcome. Our pilot study showed approximately 60% of suspected cardiac arrests were true cardiac arrests. Therefore, we expect 40% of cases for which heart runners were dispatched not to be true cardiac arrests.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
2,114 participants (actual)

Study arms

  • No intervention
    Usual Care (control arm)

    These cardiac arrests will receive standard EMS response.

  • Experimental
    HeartRunner Activation

    For these cardiac arrests, HeartRunners will be activated in addition to standard EMS response.

    Other: Activation of HeartRunners

Interventions

  • OtherActivation of HeartRunners

    Activation of volunteer citizen first-responders to respond to nearby cardiac arrests

06

What researchers measure

Primary outcomes

  1. 30-day survival

    Patient alive 30 days after date of out-of-hospital cardiac arrest

    Time frame: 30 days after date of out-of-hospital cardiac arrest

Secondary outcomes

  1. Rates of bystander defibrillation

    Percentage of patients who received defibrillation prior to EMS arrival

    Time frame: During cardiac arrest

  2. Rates of bystander cardiopulmonary resuscitation

    Percentage of patients who received bystander cardiopulmonary resuscitation prior to EMS arrival

    Time frame: During cardiac arrest

  3. Rates of return of spontaneuous circulation

    sustained circulation indicating successful resuscitation

    Time frame: Immediately after out-of-hospital cardiac arrest

  4. Rates of survival after 1 year

    percentage of patients alive 1 year after out-of-hospital cardiac arrest

    Time frame: 1 year after date of out-of-hospital cardiac arrest

  5. Rates of neurological intact survival

    percentage of patients with cerebral performance category score of 1-2

    Time frame: At hospital discharge

07

Study locations

1 site
  • Emergency Medical Services Copenhagen
    Copenhagen, Ballerup, Denmark
08

References and documents

Publications

  • Mottlau KH, Andelius LC, Gregersen R, Malta Hansen C, Folke F. Citizen Responder Activation in Out-of-Hospital Cardiac Arrest by Time of Day and Day of Week. J Am Heart Assoc. 2022 Feb;11(3):e023413. doi: 10.1161/JAHA.121.023413. Epub 2022 Jan 21. PubMed 35060395 ↗
  • Andelius L, Malta Hansen C, Lippert FK, Karlsson L, Torp-Pedersen C, Kjaer Ersboll A, Kober L, Collatz Christensen H, Blomberg SN, Gislason GH, Folke F. Smartphone Activation of Citizen Responders to Facilitate Defibrillation in Out-of-Hospital Cardiac Arrest. J Am Coll Cardiol. 2020 Jul 7;76(1):43-53. doi: 10.1016/j.jacc.2020.04.073. PubMed 32616162 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2019 to primary completion in Mar 2026, 81 months.

Of 93 non-industry interventional studies with no phase under Out-of-Hospital Cardiac Arrest, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's 81 months is above that.

Counting every sponsor, half of 95 studies reached it within 34 months; a quarter within 19 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 7, 2019
First posted
Feb 8, 2019
StartActual
May 15, 2019
Primary completionActual
Mar 1, 2026
CompletionActual
Mar 1, 2026
Last update
May 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03835403
Lead sponsor
Emergency Medical Services, Capital Region, Denmark
Collaborators
TrygFonden, Denmark
Responsible party
Fredrik Folke (MD, PhD, Head of Research, Emergency Medical Services, Capital Region, Denmark) — Principal investigator
First posted
Feb 8, 2019
Start date
May 15, 2019
Primary completion
Mar 1, 2026
Completion
Mar 1, 2026
Last update
May 15, 2026

Study contacts

Fredrik Folke, MD, PhD
principal investigator · Copenhagen EMS

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion